Jim Connolly
Director/Board Member bij VALNEVA
Profiel
James E.
Connolly currently works at Covenant House, Inc., as Director and Valneva SE, as Director from 2023.
Mr. Connolly also formerly worked at Aeras Global TB Vaccine Foundation, as President, Chief Executive Officer & Director from 2010 to 2013, Tivorsan Pharmaceuticals, Inc., as Chief Executive Officer & Director, International AIDS Vaccine Initiative, Inc., as Director from 2011 to 2013, Emergent Travel Health, Inc., as Director from 2014 to 2018, Pivotal Therapeutics, Inc., as Director in 2014, Vaxess Technologies, Inc., as Director, Ambulatus Robotics, Inc., as Director from 2020 to 2021, Wyeth Pharmaceuticals LLC, as Executive Vice President & General Manager, and Wyeth Canada ULC, as President.
Mr. Connolly received his undergraduate degree from Washington University in St. Louis.
Actieve functies van Jim Connolly
| Bedrijven | Functie | Begin |
|---|---|---|
| VALNEVA | Director/Board Member | 24-06-2022 |
| Covenant House, Inc. | Director/Board Member | - |
Eerdere bekende functies van Jim Connolly
| Bedrijven | Functie | Einde |
|---|---|---|
| Ambulatus Robotics, Inc. | Director/Board Member | 02-01-2021 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Director/Board Member | 01-10-2018 |
| PIVOTAL THERAPEUTICS INC. | Director/Board Member | 23-04-2014 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Director/Board Member | 01-01-2013 |
Tivorsan Pharmaceuticals, Inc.
 Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI. | Chief Executive Officer | - |
Opleiding van Jim Connolly
| Washington University in St. Louis | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PIVOTAL THERAPEUTICS INC. | Finance |
| VALNEVA | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Vaxess Technologies, Inc.
 Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Commercial Services |
Wyeth Canada ULC
 Wyeth Canada ULC Pharmaceuticals: MajorHealth Technology Wyeth Canada ULC manufactures and distributes pharmaceutical products. The company markets products in the areas of women's health care, neuroscience, musculoskeletal therapy, transplantation and immunology, hemophilia, and vaccines. It was founded in 1907 and is headquartered in Markham, Canada. | Health Technology |
| Covenant House, Inc. | |
| Ambulatus Robotics, Inc. | |
Tivorsan Pharmaceuticals, Inc.
Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI. | Health Technology |
